首页> 美国卫生研究院文献>other >Dual-Mechanism Gastroretentive Drug Delivery System Loaded with an Amorphous Solid Dispersion Prepared by Hot-Melt Extrusion
【2h】

Dual-Mechanism Gastroretentive Drug Delivery System Loaded with an Amorphous Solid Dispersion Prepared by Hot-Melt Extrusion

机译:通过热熔挤出制备的非晶态固体分散体的双机制胃肠药物输送系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present study, we aimed to prepare a gastroretentive drug delivery system that would be both highly resistant to gastric emptying via multiple mechanisms and would also potentially induce in situ supersaturation. The bioadhesive floating pellets, loaded with an amorphous solid dispersion, were prepared in a single step of hot-melt extrusion technology. Hydroxypropyl cellulose (Klucel MF) and hypromellose (Benecel K15M) were used as matrix-forming polymers, and felodipine was used as the model drug. The foam pellets were fabricated based on the expansion of CO2, which was generated from sodium bicarbonate during the melt-extrusion process. A 2n full factorial experimental design was utilized to investigate the effects of formulation compositions to the pellet properties. The melt-extrusion process transformed the crystalline felodipine into an amorphous state that was dispersed and “frozen” in the polymer matrix. All formulations showed high porosity and were able to float immediately, without lag time, on top of gastric fluid, and maintained their buoyancy over 12 h. The pellet-specific floating force, which could be as high as 4800 μN/g, increased significantly during the first hour, and was relatively stable until 9 h. The sodium bicarbonate percentage was found to be most significantly effect to the floating force. The ex vivo bioadhesion force of the pellets to porcine stomach mucosa was approximately 5 mN/pellet, which was more than five times higher than the gravitation force of the pellet saturated with water. Drug release was well controlled up to 12 h in the sink condition of 0.5% sodium lauryl sulphate in 0.1 N HCl. The dissolution at 1, 3, 5, and 8 h were 5 – 12%, 25 – 45%, 55 – 80%, and ≥ 75% respectively for all 11 formulations. In biorelevant dissolution medium, a supersaturated solution was formed, and the concentration was maintained at around 2 μg/ml, approximately 10-folds higher than that of the pure felodipine. All input factors significantly affected dissolution in the first 3 h, but afterwards, only drug load and hypromellose (HPMC) content had significant effects. The prepared drug delivery system has great potential in overcoming low and fluctuating bioavailability of poorly soluble drugs.
机译:在本研究中,我们旨在制备一种胃滞留药物递送系统,该系统既可以通过多种机制高度抵抗胃排空,又可以潜在地诱导原位过饱和。载有无定形固体分散体的生物粘合剂漂浮颗粒是在热熔挤出技术的单个步骤中制备的。羟丙基纤维素(Klucel MF)和羟丙甲纤维素(Benecel K15M)用作形成基质的聚合物,非洛地平用作模型药物。基于CO 2的膨胀来制造泡沫粒料,CO 2的膨胀是在熔融挤出过程中由碳酸氢钠产生的。利用2 n 全因子实验设计研究制剂组成对颗粒性质的影响。熔融挤出过程将结晶的非洛地平转变为无定形状态,该状态分散并“冻结”在聚合物基质中。所有制剂均显示出高孔隙率,能够立即在胃液顶部漂浮而没有滞后时间,并在12小时内保持浮力。丸粒比漂浮力可能高达4800μN/ g,在第一个小时内显着增加,并且相对稳定,直到9 h。发现碳酸氢钠百分数对浮力的影响最大。药丸对猪胃黏膜的离体生物粘附力约为5 mN /丸,比用水饱和的药丸的重力高出五倍以上。在0.1%HCl中的0.5%月桂基硫酸钠的吸收条件下,长达12小时的药物释放得到了很好的控制。对于所有11种配方,在1、3、5和8 h时的溶出度分别为5 – 12%,25 – 45%,55 – 80%和≥75%。在生物相关的溶出介质中,形成了过饱和溶液,其浓度保持在约2μg/ ml,比纯非洛地平高约10倍。在开始的3小时内,所有输入因素均显着影响溶出度,但此后,仅载药量和羟丙甲纤维素(HPMC)含量具有显着影响。所制备的药物递送系统具有克服难溶药物的低和波动生物利用度的巨大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号